Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, announced that its MARINE trial, a Phase 3 clinical trial of AMR101, has completed patient enrollment and randomization into the treatment phase of this trial.
Vertex Pharmaceuticals Inc. said that a study showed some patients who take its hepatitis C drug candidate telaprevir may be able to complete their treatment sooner.
Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.
Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.
Doctors can't tell if Leif Utoft Bollesen's mild memory loss will remain an annoyance or worsen, but experimental checks of the Minnesota man's aging brain may offer clues.
The World Health Organization has declared the swine flu pandemic officially over, months after many national authorities started canceling vaccine orders and shutting down hot lines as the disease ebbed from the headlines.
Merck, the world's second-biggest drugmaker by revenue, has received inquiry letters from both the Department of Justice and the Securities and Exchange Commission seeking information about activities in a number of countries and reference the Foreign Corrupt Practices Act.
A unique clinical development program speeds Phase 3 trials.
Qlucore Omics Explorer enables scientists to analyse very large data sets using combination of statistical methods and visualization techniques, without having to be a statistics or computer expert.
Scientists at the Dana-Farber Cancer Institute—one of the leading cancer research and care centers in the United States—have pioneered a new approach to manage the massive amount of data needed to accelerate medical research.
Sigma Life Science and SwitchGear Genomics, Inc. announced a joint project to develop and distribute a novel microRNA target reporter system.
The DEPArray System is a cell microarray implementing patented technology for individual rare cell detection and recovery from suspensions.
AB SCIEX, a global leader in life science analytical technologies, today announced a collaboration with the Centers for Disease Control and Prevention (CDC) and the CDC Foundation to facilitate the use of mass spectrometry technologies in clinical laboratories for hormone testing.
Horizon Discovery announced that it is to be part of a new four year EUFP7 personalized medicine consortium. The PREDICT Consortium was established to coordinate single drug clinical trials and define patient-specific drug sensitivity pathways and biomarkers predictive of drug response.
Genetic differences that make some people susceptible to developing meningococcal meningitis and septicaemia, and others naturally immune, are revealed in a new study of over 6,000 people.